Xvivo Perfusion AB (publ) (XVIPF) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Xvivo Perfusion AB (publ) (XVIPF).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $33.45

Daily Change: $0.00 / 0.00%

Range: $0 - $0

Market Cap: $1,053,658,304

Volume: 0

Performance Metrics

1 Week: 19.75%

1 Month: -0.30%

3 Months: -14.95%

6 Months: -26.57%

1 Year: -1.07%

YTD: -27.73%

Company Details

Employees: 180

Sector: Health technology

Industry: Medical specialties

Country: Sweden

Details

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. The company was incorporated in 1998 and is headquartered in Mölndal, Sweden.

Selected stocks

American Aires Inc. (AAIRF)

Riocan Real Estate Investment Trust (RIOCF)

Loblaw Companies Limited (LBLCF)